Literature DB >> 17499443

Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates.

M J Reinhard1, C H Hinkin, T R Barclay, A J Levine, S Marion, S A Castellon, D Longshore, T Newton, R S Durvasula, M N Lam, H Myers.   

Abstract

While it has long been recognized that self-reported drug use may be at variance with objectively obtained evidence such as urine toxicology assays, few studies have explored the behavioral correlates of such discrepancies. Here we compared self-reported and objective measures of stimulant drug use for 162 HIV infected individuals and identified a sub-group with discrepancies between data obtained via the two methods. Results showed poorer neurocognitive performance (attention, learning/memory) and lower medication adherence rates for the discrepant group as compared to those who either acknowledged their drug use or accurately denied recent stimulant use. Using the Millon Clinical Multiaxial Inventory-III, it was also found that those in the discrepant group were more hesitant to reveal psychopathology. Comparisons of self-reported and objectively measured medication adherence data are also discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499443      PMCID: PMC2679746          DOI: 10.1016/j.addbeh.2007.04.006

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  26 in total

1.  Drug use, self report and urinalysis.

Authors:  B Kilpatrick; M Howlett; P Sedgwick; A H Ghodse
Journal:  Drug Alcohol Depend       Date:  2000-02-01       Impact factor: 4.492

2.  The validity of self-reported drug use in non-treatment seeking individuals with cocaine dependence: correlation with biochemical assays.

Authors:  I Elman; S Krause; H C Breiter; R L Gollub; J Heintges; W A Baumgartner; B R Rosen; D R Gastfriend
Journal:  Am J Addict       Date:  2000

3.  Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions.

Authors:  S T Chermack; J Roll; M Reilly; L Davis; U Kilaru; J Grabowski
Journal:  Drug Alcohol Depend       Date:  2000-04-01       Impact factor: 4.492

4.  Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.

Authors:  Linda Chang; Thomas Ernst; Oliver Speck; Charles S Grob
Journal:  Am J Psychiatry       Date:  2005-02       Impact factor: 18.112

5.  The effect of recent stimulant use on sustained attention in HIV-infected adults.

Authors:  Andrew J Levine; David J Hardy; Eric Miller; Steven A Castellon; Douglas Longshore; Charles H Hinkin
Journal:  J Clin Exp Neuropsychol       Date:  2006-01       Impact factor: 2.475

Review 6.  Self-report among injecting drug users: a review.

Authors:  S Darke
Journal:  Drug Alcohol Depend       Date:  1998-08-01       Impact factor: 4.492

7.  Comparing self-reported cocaine use with repeated urine tests in outpatient cocaine abusers.

Authors:  R N Ehrman; S J Robbins; J W Cornish
Journal:  Exp Clin Psychopharmacol       Date:  1997-05       Impact factor: 3.157

8.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG).

Authors:  M A Chesney; J R Ickovics; D B Chambers; A L Gifford; J Neidig; B Zwickl; A W Wu
Journal:  AIDS Care       Date:  2000-06

9.  Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team.

Authors:  B R Edlin; K L Irwin; S Faruque; C B McCoy; C Word; Y Serrano; J A Inciardi; B P Bowser; R F Schilling; S D Holmberg
Journal:  N Engl J Med       Date:  1994-11-24       Impact factor: 91.245

10.  Public health implications of antiretroviral therapy and HIV drug resistance.

Authors:  M A Wainberg; G Friedland
Journal:  JAMA       Date:  1998-06-24       Impact factor: 56.272

View more
  15 in total

Review 1.  Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices.

Authors:  Lizheng Shi; Jinan Liu; Yordanka Koleva; Vivian Fonseca; Anupama Kalsekar; Manjiri Pawaskar
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Prospective memory in substance abusers at treatment entry: associations with education, neuropsychological functioning, and everyday memory lapses.

Authors:  Michael Weinborn; Steven Paul Woods; Stephanie O'Toole; Emily J Kellogg; Jonson Moyle
Journal:  Arch Clin Neuropsychol       Date:  2011-09-08       Impact factor: 2.813

3.  Neurocognitive impact of substance use in HIV infection.

Authors:  Desiree A Byrd; Robert P Fellows; Susan Morgello; Donald Franklin; Robert K Heaton; Reena Deutsch; J Hampton Atkinson; David B Clifford; Ann C Collier; Christina M Marra; Benjamin Gelman; J Allen McCutchan; Nichole A Duarte; David M Simpson; Justin McArthur; Igor Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

4.  Association between use of specific drugs and antiretroviral adherence: findings from MACH 14.

Authors:  M I Rosen; A C Black; J H Arnsten; K Goggin; R H Remien; J M Simoni; C E Golin; D R Bangsberg; H Liu
Journal:  AIDS Behav       Date:  2013-01

Review 5.  Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies.

Authors:  Q Abdool Karim; C Baxter; S Abdool Karim
Journal:  BJOG       Date:  2014-10       Impact factor: 6.531

Review 6.  Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis.

Authors:  Lizheng Shi; Jinan Liu; Vivian Fonseca; Philip Walker; Anupama Kalsekar; Manjiri Pawaskar
Journal:  Health Qual Life Outcomes       Date:  2010-09-13       Impact factor: 3.186

7.  Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study.

Authors:  Desiree A Byrd; Jessica Robinson-Papp; Monica Rivera Mindt; Letty Mintz; Kathryn Elliott; Quenesha Lighty; Susan Morgello
Journal:  J Int Neuropsychol Soc       Date:  2013-02-28       Impact factor: 2.892

8.  Prevalence and patient awareness of medical comorbidities in an urban AIDS clinic.

Authors:  Jeffrey J Weiss; Georgina Osorio; Elizabeth Ryan; Sue M Marcus; Dawn A Fishbein
Journal:  AIDS Patient Care STDS       Date:  2010-01       Impact factor: 5.078

Review 9.  Functional consequences of HIV-associated neuropsychological impairment.

Authors:  Ashley A Gorman; Jessica M Foley; Mark L Ettenhofer; Charles H Hinkin; Wilfred G van Gorp
Journal:  Neuropsychol Rev       Date:  2009-05-27       Impact factor: 7.444

10.  Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men.

Authors:  Jeffrey T Parsons; William J Kowalczyk; Michael Botsko; Julia Tomassilli; Sarit A Golub
Journal:  AIDS Behav       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.